• Charles River entered a research collaboration with the FDA and Labcorp to develop tools assessing drug abuse potential.
• The partnership aims to improve assessment sensitivity, accuracy and consistency across laboratories, potentially informing regulatory decisions under the Controlled Substances Act.
• Researchers will use behavioral economic models to analyze self-administration data, comparing substances’ reinforcing properties with those of known drugs of abuse.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610221630BIZWIRE_USPR_____20261022_BW662205) on October 22, 2026, and is solely responsible for the information contained therein.